{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:06:01Z","timestamp":1795017961331,"version":"4.10.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:p>\n                    The risk of placenta accreta spectrum (PAS) associated with in vitro fertilization and embryo transfer (IVF-ET) in the context of mid-trimester pregnancy loss remains unclear. This study aimed to investigate the impact of IVF-ET on the incidence of PAS and identify the risk factors among women undergoing pregnancy loss following fetal demise or inevitable miscarriage during the second trimester. In our retrospective cohort study, we analyzed women who experienced second-trimester fetal loss due to fetal demise or inevitable miscarriage at the Sixth Affiliated Hospital of Sun Yat-sen University between January 2013 and October 2023. The participants were categorized into IVF-ET (n\u2005=\u200593) and non-IVF-ET (n\u2005=\u2005134) groups. The primary outcome was the incidence of PAS, which was diagnosed clinically or pathologically. Secondary outcomes included morbid PAS, postpartum hemorrhage, and other complications. Our results indicated that the IVF-ET group had a significantly greater risk of experiencing PAS (39.8% vs 17.9%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and morbid PAS (17.2% vs 3.7%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) compared to the non-IVF-ET group. The median postpartum blood loss was greater (230.0 [120.0\u2013600.0] mL vs 120.0 [70.0\u2013200.0] mL,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and the rates of postpartum hemorrhage (30.1% vs 12.7%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001) and retained products of conception persisting &gt;4 weeks (38.7% vs 19.4%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) were also greater in the IVF-ET group. Multivariate analysis revealed IVF-ET (adjusted odds ratio [aOR]\u2005=\u20053.13;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002), a hysteroscopic history (aOR\u2005=\u20053.58;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02), and uterine abnormalities (aOR\u2005=\u20053.74;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.02) as independent risk factors for PAS. In the IVF-ET group, compared with fresh embryo transfer, cryopreserved embryo transfer (aOR\u2005=\u20053.52;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.01) was associated with a markedly higher risk of PAS (50.9% vs 22.2%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006) and remained an independent risk factor after adjustment (aOR\u2005=\u20053.52;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.01). Among women with mid-trimester pregnancy loss, those who underwent IVF-ET, especially cryopreserved embryo transfer, had a high risk of PAS, leading to increased hemorrhagic morbidity and complications. These findings highlight the need for enhanced preoperative assessment, vigilant management, and strategies to preserve fertility in this high-risk population.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048427","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:02:42Z","timestamp":1777273362000},"page":"e48427","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["In vitro fertilization increases the risk of placenta accreta spectrum in second-trimester pregnancy loss: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-5847","authenticated-orcid":false,"given":"Si","family":"Li","sequence":"first","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Cheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Department of Obstetrics, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Xu","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Guo","sequence":"additional","affiliation":[{"name":"Prenatal Diagnostic Center, Guangzhou Women and Children\u2019s Medical Center, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Gou","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"},{"name":"Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders.","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/AOG.0000000000005229","article-title":"Placenta accreta spectrum.","volume":"142","author":"Einerson","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1080\/14767058.2018.1442429","article-title":"Maternal and neonatal outcomes of placenta increta and percreta from a multicenter study in China.","volume":"32","author":"Zhang","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.placenta.2022.06.009","article-title":"Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: a multicenter hospital-based study.","volume":"126","author":"Ming","year":"2022","journal-title":"Placenta"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/humupd\/dml049","article-title":"Mid-trimester induced abortion: a review.","volume":"13","author":"Lalitkumar","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/GMIT.GMIT_125_20","article-title":"Hysteroscopy and retained products of conception: an update.","volume":"10","author":"Foreste","year":"2021","journal-title":"Gynecol Minim Invasive Ther"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1038\/s41598-021-88551-7","article-title":"Antenatal diagnosis of placenta accreta spectrum after in vitro fertilization-embryo transfer: a systematic review and meta-analysis.","volume":"11","author":"Matsuzaki","year":"2021","journal-title":"Sci Rep"},{"key":"R10-20260622","first-page":"571","article-title":"Clinical characteristics and perinatal outcomes of prenatal missed diagnosis of placenta accreta spectrum disorders.","volume":"35","author":"Wang","year":"2024","journal-title":"Chin J Reprod Health"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260622","first-page":"169","article-title":"ACOG Committee opinion. Number 266, January 2002: placenta accreta.","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bpobgyn.2020.06.007","article-title":"A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders.","volume":"72","author":"Jauniaux","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.09.001","article-title":"Special report of the society for maternal-fetal medicine placenta accreta spectrum ultrasound marker task force: consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum.","volume":"224","author":"Shainker","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260622","first-page":"27","article-title":"Risk factors and sonographic findings associated with the type of placenta accreta spectrum disorders.","volume":"54","author":"Zhang","year":"2019","journal-title":"Chinese J Obstet Gynecol"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/humrep\/deab070","article-title":"The influence of frozen-thawed and fresh embryo transfer on utero-placental (vascular) development: the Rotterdam Periconception cohort.","volume":"36","author":"van Duijn","year":"2021","journal-title":"Hum Reprod"},{"key":"R18-20260622","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/jog.16058","article-title":"Differences in perinatal complications and serum hormone levels due to uterine endometrial preparation methods in frozen-thawed embryo transfer.","volume":"50","author":"Yoshihara","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2024.02.040","article-title":"Risk factors for placenta accreta spectrum in pregnancies conceived after frozen-thawed embryo transfer in a hormone replacement cycle.","volume":"296","author":"Fujita","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:12Z","timestamp":1786039692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":16,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048427","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2025-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}